Skip links and keyboard navigation

    Media Statements

    Coat of ArmsMedia Release
    Minister for Innovation, Science and the Digital Economy and Minister for Small Business
    The Honourable Leeanne Enoch

    Life-saving research receives Advance Queensland funding boost

    Minister for Innovation, Science and the Digital Economy and Minister for Small Business
    The Honourable Leeanne Enoch

    Thursday, March 03, 2016

    Life-saving research receives Advance Queensland funding boost

    Ground-breaking research with the potential to save the lives of babies and toddlers suffering from a common lung disease will be boosted with Queensland Government funding.

    Minister for Innovation, Science and the Digital Economy Leeanne Enoch today announced $50,000 funding for Brisbane-based healthcare company Ellume to help detect a virus that commonly causes lung infections in babies.

    “The funding, provided through the Knowledge Transfer Partnership Program, has enabled Ellume to work on an innovative ultra-sensitive test to help diagnose Respiratory Syncytial Virus (RSV), which is one of the most common causes of childhood lung infections,” Ms Enoch said.

    Ellume will partner with molecular virologist Professor Paul Young, an RSV expert and member of the University of Queensland’s Australian Infectious Diseases Research Centre to carry out the RSV research.

    The Advance Queensland grant will also help fund a recent Queensland University of Technology post-graduate student to work on the project.

    RSV can result in hospitalisation for babies, middle ear infections, pneumonia and bronchiolitis for children as well as immune-compromised adults and those with heart or lung conditions.

    Opening Ellume’s expanded East Brisbane facility, Ms Enoch said the company was an example of Queensland talent and innovative thinking being nurtured by the Palaszczuk Government’s $180 million Advance Queensland initiative.

    “A total of $1.16 million has been awarded in the first round of the Advance Queensland Knowledge Transfer Partnership program, with more than $930,000 going directly to businesses and the remainder shared by universities for mentoring and coordination of the partnerships,” she said.

    “These grants are helping to develop innovative solutions across the state through collaboration between businesses and graduate students in a number of industries and applications.

    “Ellume is a perfect example of what it means to take an innovative idea, work collaboratively and turn it into a product with the potential to improve health outcomes and create commercial opportunities.

    “These opportunities are not only creating jobs now, but also the jobs of the future.”

    Ellume has been recognised for its Respirio Flu Test, a non-invasive simple at-home test for the detection of influenza A and B and is also working on a hand-held device for general practitioners to perform rapid tests in their offices – allowing GPs to test for up to four viruses at once and receive results in minutes.

    Ellume Chairman Paul Darrouzet said the company would deliver global healthcare solutions while contributing to the local economy.

    “It’s an exciting time for Queensland and in particular Brisbane for our company to offer world-leading diagnostic devices right here,” he said.

    “We believe this technology will help revolutionise the way people access healthcare.”

    Ellume’s unique fluorescent nanoparticle technology, used in the Respirio Flu Test, won it the title of Emerging Company of the Year at the Johnson & Johnson Innovation 2015 Industry Excellence Awards.

    Media contact: Daniel Lato 0438 830 201